Phase I/II Study of Flavopiridol in Kaposis Sarcoma


NIH 2000 R01 CA	Phase I/II Study of Flavopiridol in Kaposi's Sarcoma Browning, Philip J. / Vanderbilt University Medical Center	$160,124
NIH 1999 R01 CA	Phase I/II Study of Flavopiridol in Kaposi's Sarcoma Browning, Philip J. / Vanderbilt University Medical Center
NIH 1999 R01 CA	Phase I/II Study of Flavopiridol in Kaposis Sarcoma Browning, Philip J. / Vanderbilt University Medical Center
NIH 1998 R01 CA	Phase I/II Study of Flavopiridol in Kaposi's Sarcoma Browning, Philip J. / Vanderbilt University Medical Center
NIH 1998 R01 CA	Phase I/II Study of Flavopiridol in Kaposis Sarcoma Browning, Philip J. / Vanderbilt University Medical Center
NIH 1998 R01 CA	Phase I/II Study of Flavopiridol in Kaposis Sarcoma Browning, Philip J. / Vanderbilt University Medical Center
NIH 1997 R01 CA	Phase I/II Study of Flavopiridol in Kaposi's Sarcoma Browning, Philip J. / Vanderbilt University Medical Center

Van Dross, Rukiyah; Yao, Shan; Asad, Shaheena et al. (2005) Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells. J Natl Cancer Inst 97:656-66

Ikpeazu, C; Davidson, M K; Halteman, D et al. (2000) Donor origin of circulating endothelial progenitors after allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 6:301-8